Applied Therapeutics, Inc. (APLT)

Key Insights

• Applied Therapeutics, Inc. (APLT) has been acquired by Cycle Group Holdings Limited through a tender offer and merger, resulting in the cancellation of APLT's outstanding shares and stock options.
• The Merger Consideration includes $0.088 per share in cash plus one non-tradeable contingent value right, providing APLT shareholders with a mix of immediate cash and potential future upside.
• The acquisition eliminates APLT's public company status, ending its reporting obligations under SEC regulations such as filing Form 4 insider transaction reports.